Gleiss Lutz has advised Japanese Sumitomo Corporation on the acquisition of Bayer AG's Metribuzin Solo business in Latin America, Asia-Pacific and Canada. Metribuzin Solo is a plant protection herbicide. Around 75 percent of global usage is linked to the cultivation of soybeans, potatoes, and sugar cane.
According to the agreement, the Metribuzin Solo business, including associated trademark rights, product approvals, inventories, sales contracts, and technical know-how, will be acquired by Summit Agro, a wholly-owned subsidiary of Sumitomo Corporation.
Sumitomo Corporation is a listed Japanese integrated trading and business investment company. The diversified group, with approximately 80,000 employees worldwide, operates in 65 countries and regions.
The following Gleiss Lutz team led by Dr. Anselm Christiansen (lead, partner, Stuttgart), Josefine Wiegand (Berlin) und Alexandra Brücher (all M&A, Stuttgart) has advised Sumitomo Corporation:
Dr. Michael Burian (partner, M&A, Frankfurt), Dr. Enno Burk (partner), Sophie Römer (both Public Law), Dr. Hannah Bug (counsel, all Berlin), Dr. Benedikt Burger (counsel, both IP/Tech, Stuttgart), Dr. Birgit Colbus (counsel), Dr. Saskia Kirchgeßner (both Competition/Antitrust, both Frankfurt), Aylin Hoffs (counsel, Foreign Trade Law, Düsseldorf), Dr. Ocka Stumm (partner), Julian Kettemer (both Tax, both Frankfurt), Simon Clemens Wegmann (Data Protection, Berlin).
Gleiss Lutz has a leading Japan practice and regularly advises Japanese companies on M&A transactions.
Forward
